- The GOP Says Expanding Medicaid Fueled The Opioid Crisis. This Study Shows Otherwise.
- The Success Of Medicaid Expansion, Explained In 5 Charts
- Arkansas Scraps Medicaid Coverage For Thousands Of Individuals
- Number Of New Heroin Users Drops Dramatically, But Meth, Marijuana Use Up, Survey Says
- There Are Solutions To The Opioid Epidemic. Here’s How You Convince People To Support Them.
- Young People With Opioid Addiction Not Getting Proper Treatment
- How the Smallest State (Rhode Island) is Defeating America’s Biggest Addiction Crisis
- Nearly 30 Percent Of Patients Prescribed Opioids Had No Recorded Pain Diagnoses
- One In Four Older Adults Prescribed A Benzodiazepine Goes On To Risky Long-Term Use
- Dr. Jana Burson Blog: Buprenorphine Prescribed in Two Settings – It Depends on the Needs of the Patient
- Highest Opioid-Related Mortality Seen In Construction Jobs
- 4 Factors That Add To Stigma Surrounding Opioid-Use Disorder
- Poorest Americans Most Likely To Have Used Prescription Opioids—And Most Users View Opioids Positively
LINKS TO ADDITIONAL NEWS OF INTEREST
- The Most Essential Books for Wrapping Your Head Around the Opioid Crisis – 9/10/18
- Titan Awarded NIDA Grant For The Development Of A Nalmefene Implant For The Prevention Of Opioid Addiction Relapse – 9/11/18
“Contradicting a popular conservative talking point, new research shows that Medicaid expansion under the Affordable Care Act helped states treat residents with addiction and didn’t change prescription painkiller fill rates.
“This supports the idea that Medicaid expansion has been beneficial in increasing the number of people receiving an important addiction treatment,” said Brendan Saloner, assistant professor at the Johns Hopkins Bloomberg School of Public Health and lead author of the study, which was published this month in the journal JAMA Network Open.
The researchers compared California, Maryland and Washington, where Medicaid was expanded under the ACA, to Florida and Georgia, where it wasn’t, and found that prescription fills for the addiction medication buprenorphine combined with the overdose reversal antidote naloxone increased significantly in expansion counties. In comparison, prescription fills for opioid painkillers remained about the same after Medicaid expansion, although more patients paid for those prescriptions using Medicaid.”
Source: HuffingtonPost.com – August 23, 2018
“The momentum was with Medicaid this week: Nebraska is very close (pending a court decision) to putting Medicaid expansion on the ballot in November, and Maine’s highest court ruled that the state should finally expand Medicaid, as the citizenry voted to do last year.
And a new report out of Ohio, documenting the first five years of expanded Medicaid in the Buckeye State, gave us a clear picture of the stakes in these debates. The Ohio report is a rigorously collected and extensive data set on what happens in a state when it expands Medicaid with no frills (i.e., without a work requirement) and lets the program work its will for a few years.
As is our preference here at Vox, we can walk through the findings with the help of some handy charts.”
Source: Vox.com – August 24, 2018
“Arkansas has removed thousands of individuals from its Medicaid program for failing to comply with work requirements — a first in the 53-year history of the federal health insurance program for the poor.
More than 4,300 Medicaid recipients in Arkansas have lost coverage after failing to meet the state’s new work requirements, which were approved by the Trump administration and took effect in June.
“Personal responsibility is important. We will continue to do everything we can to ensure those who qualify for the program keep their coverage, but it is equally important that we make sure those who no longer qualify are removed,” said Arkansas Gov. Asa Hutchinson.”
Source: TheHill.com – September 12, 2018
See related article below:
Medicaid Rolls Set To Be Slashed Under Trump-Approved Work Rules
“The thousands of people who lost Medicaid coverage this month in Arkansas for not following newly implemented work requirements may be a sign of what’s to come in other GOP-led states.
Indiana and New Hampshire are slated to implement their Medicaid work requirements next year, and a slew of other states are awaiting approval from the Trump administration.
Arkansas has served as a test case of sorts since it was the first state to implement work requirements, and this month it became the first state to kick off beneficiaries for not following them.
The state removed more than 4,000 people from the Medicaid rolls, with some estimates saying that number could climb to 50,000 when the requirements are fully implemented in 2019.”
Source: The Hill.com – September 13, 2018
“Far fewer people in the United States started using heroin last year, but the decline among young new 18- to 25-year-old heroin users was almost
imperceptible – and that age group saw a big jump in methamphetamine and marijuana use, the federal government reported Friday.
The 2017 National Survey on Drug Use and Health emphasizes what it calls these “transitional aged youth” because they have higher rates of cigarette use, alcohol abuse and heroin use disorder, and they use more cocaine, meth and LSD, than people both younger and older.
The report, released by the Substance Abuse and Mental Health Services Administration, showed one positive change among 18- to 25-year-olds: They’re misusing prescription opioids less. In 2015, SAMHSA estimated 8.5 percent of people in that age range misused prescription opioids; that dropped to just over 7 percent in 2017.”
Source: USAToday.com -September 14, 2018
A new study looks at different messages for strategies to combat the opioid epidemic. Some work better than others.
“There are plenty of evidence-based ideas that could help end the opioid epidemic, from more access to addiction treatment to harm reduction efforts. But the policy proposals to enact such ideas often have trouble getting off the ground — largely thanks to resistance from the general public and politicians, even in the midst of what amounts to the deadliest drug overdose crisis in US history.
A new survey of more than 5,500 Americans by Civis Analytics provides some hints for advocates looking to build public support for policy responses to the opioid crisis. The survey gauged public support for medications used to treat opioid addiction and needle exchanges, both of which have decades of evidence to support them. The analysis then compared how different messages affect levels of support among the general public.”
Source: Vox.com – September 13, 2018
“The vast majority of young people struggling with addiction to opioids are not receiving medications that have been recommended to treat their disease, a new study shows.
Only one in four received one of the medications approved by the U.S. Food and Drug Administration – methadone, buprenorphine or naltrexone – within three months of their diagnosis, according to the report in JAMA Pediatrics.
The situation was even worse for the younger people with addiction, researchers found. Just one in 21 adolescents under age 18 received one of the guideline-recommended medications, researchers found.
“This study shows that the great majority of youth are not receiving treatment recommended in evidence-based guidelines,” said the study’s lead author, Dr. Scott Hadland, a pediatrician and addiction specialist at the Grayken Center for Addiction at the Boston Medical Center. “That’s really concerning because the data suggest that when people do receive medication they are much more likely to remain in treatment.”
Source: WHBL.com – September 10, 2018
Categories: Addiction, Buprenorphine, Medication-Assisted Treatment (MAT), Methadone, naltrexone, News Updates, Opioid Abuse/Addiction
Tags: Addiction, Buprenorphine, Medication-Assisted Treatment, Methadone Treatment, naltrexone
“Inside Rhode Island’s Adult Correctional Institutions in this Providence suburb, while facing a felony charge of drug possession with intent to deliver, Roussell was offered a chance to break his addiction through a groundbreaking new program. “I was very surprised to find out that I was able to have methadone in prison,” he says.
Every day while locked up, Roussell drank a 55-milligram dose of methadone, the medicine doctors have used for 50 years to help people get off heroin. “It was very comfortable, very helpful,” says Roussell.
Roussell got treatment for his addiction in prison because, two years ago, Rhode Island decided to do something no other state has done. In 2016, it began offering its prison inmates all three medications approved to treat opioid addiction: methadone, Suboxone, and Vivitrol. About 350 Rhode Island prisoners each month take one of the three medicines. Crucially, they continue their treatment after their release, usually through the state’s Medicaid program, when they’re at the greatest risk of a relapse and a fatal overdose.”
Source: Politico.com – August 25, 2018
Categories: Drug Courts & Criminal Justice, Medication-Assisted Treatment (MAT), Medication-Assisted Treatment (MAT), Methadone, News Updates, Opioid Abuse/Addiction
Tags: Addiction, Criminal Justice, Methadone Treatment
“Nearly 30 percent of U.S. patients prescribed opioids by doctors over the course of a decade had no recorded pain diagnosis, according to a new letter published in the Annals of Internal Medicine.
Researchers analyzed data from 31,943 visits in which a patient age 18 or older received an opioid prescription, part of the National Ambulatory Medical Care Survey. The Centers for Disease Control and Prevention conducts this annual survey to track why people visit physician offices, what diagnoses, services and treatments they receive, and what medications are prescribed.
The research team did not make a conclusion that these prescriptions were inappropriate, said Tisamarie Sherry, an associate physician at Brigham and Women’s Hospital in Boston and the letter’s lead author. There was not enough information to make that judgment, Sherry said.”
Source: PBS.org: September 10, 2018
“They may start as well-intentioned efforts to calm anxiety, improve sleep or ease depression. But prescriptions for sedatives known as benzodiazepines may lead to long-term use among one in four older adults who receive them, according to new research.
That’s despite warnings against long-term use of these drugs, especially among older people, because they can increase the risk of car crashes, falls and broken hips, as well as causing other side effects.
The new study, published in JAMA Internal Medicine by a team from the University of Michigan, VA and University of Pennsylvania, looked at benzodiazepine use by low-income older adults in a Pennsylvania program that helps with drug costs.
The researchers say their findings point to a strong need for better education of healthcare providers, and the public, about the risks associated with these drugs.”
Source: MedicalExpress.com – September 10, 2018
Dr. Jana Burson Blog: Buprenorphine Prescribed in Two Settings – It Depends on the Needs of the Patient
“It’s very confusing. Even medical professionals get confused, so imagine how it is for patients.
I’m referring to the different setting where buprenorphine can be prescribed for the treatment of opioid use disorder.
Opioid treatment programs deliver care for patients with opioid use disorder in a much more structured setting. OTPs are regulated by sets of federal, state, and sometimes even local agencies. This limits flexibility when responding to changing patient needs, but provides a much more structured – some would say rigid – treatment setting.
So which setting is best? It depends on the needs of the patient.”
Read more at: https://janaburson.wordpress.com/2018/08/23/buprenorphine-prescribed-in-two-settings/Source: JanaBurson.com – August 23, 2018
See recent Dr. Burson Blog: Pregnant Women with Opioid Use Disorder available at: https://janaburson.wordpress.com/2018/09/09/pregnant-women-with-opioid-use-disorder/
Laurel Harduar Morano, Ph.D., from the CDC’s National Institute for Occupational Safety and Health in Cincinnati, and colleagues used mortality data from the National Occupational Mortality Surveillance system to examine unintentional or undetermined drug overdose mortality within 26 occupation groups. Data from the 21 participating states were included. Drug overdose mortality and total mortality were compared using Proportional mortality ratios (PMRs) indirectly standardized for age, sex, race, year, and state.
The researchers found that construction occupations had the highest PMRs for drug overdose deaths and for both heroin-related overdose deaths (1.46) and prescription opioid-related overdose deaths (1.34). Extraction (e.g., mining, oil and gas extraction), and health care practitioners had the highest PMRs from methadone, natural and semisynthetic opioids, and synthetic opioids other than methadone (1.39 and 1.81, respectively).
“Incorporating workplace research and targeted interventions might benefit the opioid epidemic response,” the authors write.”
The CDC report can be accessed at: https://www.cdc.gov/mmwr/volumes/67/wr/mm6733a3.htm?s_cid=mm6733a3_w
Source: MedicalExpress.com – September 13, 2018
“Even as America’s opioid epidemic has increased, the stigma surrounding substance-use disorders continues to be a major barrier to wider implementation of effective treatments that prevent overdoses and deaths.
The AMA Opioid Task Force offers a wealth of educational tools and practice resources to aid physicians in removing stigma surrounding opioid-use disorder and effective treatment for the condition.
Among them is a JAMA Viewpoint essay, “Confronting the Stigma of Opioid Use Disorder—and Its Treatment,” that provides insight on the harmful effects of stigma with medication-assisted treatment of opioid-use disorder.
The essay’s co-authors—Yngvild Olsen, MD, MPH, and Joshua M. Sharfstein, MD—describe four factors that contribute to stigma on opioid-use disorder and offer guidance on how they can be overcome.
- The understanding of opioid-use disorder as a medical illness is still overshadowed by its misconception as a moral weakness or a willful choice.
- The separation of opioid-use disorder treatment has meant clinicians overlook other health issues.
- Loaded language furthers stigma associated with the condition.
- The criminal justice system’s unwillingness to yield to medical judgment in the treatment of opioid-use disorders..
Source: AMA-ASSN.org – September 13, 2018
Poorest Americans Most Likely To Have Used Prescription Opioids—And Most Users View Opioids Positively
“Among older Americans, the poorest are the most likely to have used prescription opioids, according to a University at Buffalo study providing new insights into unexplored contours of the opioid crisis.
The study also raises important questions about access to pain management options for the disadvantaged in the current climate of the opioid epidemic. “The poor had about double the rate of opioid use compared to wealthier groups,” says Hanna Grol-Prokopczyk, an assistant professor in UB’s sociology department and the study’s author. “The poor are the ones who have been disproportionately relying on these medications—and it’s not always easy for them to switch to other ways of dealing with chronic pain.”
Grol-Prokopczyk, an expert in chronic pain, says the poor are less healthy than the general population and experience more pain, but her findings, which focused on prescribed use, not misuse, of opioids, indicate that even for the same pain level, the poor were more likely to be using prescription opioids.”
Source: MedicalExpress.com – September 12, 2018
Categories: News Updates